Discontinued — last reported Q1 '25
Year-over-year, this metric declined by 100.0%, from $32.75M to $0.00. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Goodwill as a result of acquisitions shows a downward trend with a -100.0% CAGR.
An increase suggests active inorganic growth and investment in new cardiovascular technologies or market expansion, while a decrease or zero balance indicates a period of organic focus or potential impairment of past acquisitions.
This metric represents the premium paid over the fair value of net identifiable assets during the acquisition of busines...
Comparable to 'Goodwill' or 'Acquisition-related intangible assets' reported in segment-level disclosures by large-cap medical device peers.
mdt_segment_cardiovascular_goodwill_as_a_result_of_acquisitions| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.00M | $13.75M | $13.75M | $13.75M | $13.75M | $66.00M | $660.00M | $0.00 | $0.00 | $32.75M | $32.75M | $32.75M | $32.75M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | -77.8% | +0.0% | +0.0% | +0.0% | +380.0% | +900.0% | -100.0% | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | -77.8% | +380.0% | >999% | -100.0% | -100.0% | -50.4% | -95.0% | — | — | -100.0% | -100.0% | -100.0% | -100.0% |